The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non‐small‐cell lung cancer-Reference-Cited by-同舟云学术

The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non‐small‐cell lung cancer

Published:2021-01 Issue:1 Volume:10 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Lei Yuanyuan¹,Zhang Guochao¹,Zhang Chaoqi¹,Xue Liyan²,Yang Zhenlin¹,Lu Zhiliang¹,Huang Jianbing¹,Zang Ruochuan¹,Che Yun¹,Mao Shuangshuang¹,Fang Lingling¹,Liu Chengming¹,Wang Xinfeng¹,Zheng Sufei¹,Sun Nan¹,He Jie¹

Affiliation:

1. Department of Thoracic Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of Pathology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

Fundamental Research Funds for Central Universities of the Central South University

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1231

Reference26 articles.

1. Clinical activity of programmed cell death 1 (PD‐1) blockade in never, light, and heavy smokers with non‐small‐cell lung cancer and PD‐L1 expression >/=50;Gainor JF;Ann Oncol,2020

2. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

3. Tumor mutational load predicts survival after immunotherapy across multiple cancer types